中华检验医学杂志
中華檢驗醫學雜誌
중화검험의학잡지
CHINESE JOURNAL OF LABORATORY MEDICINE
2010年
10期
948-952
,共5页
唐少华%陈栋%林晓%徐峰%李焕铮%刘晓丹%徐献宗%秦方%吕建新
唐少華%陳棟%林曉%徐峰%李煥錚%劉曉丹%徐獻宗%秦方%呂建新
당소화%진동%림효%서봉%리환쟁%류효단%서헌종%진방%려건신
血友病A%因子Ⅷ%产前诊断
血友病A%因子Ⅷ%產前診斷
혈우병A%인자Ⅷ%산전진단
Hemophilia A%Factor Ⅷ%Prenatal diagnosis
目的建立临床不同背景情况下HA患儿产前诊断方案.方法对前来要求作HA产前诊断的15例孕妇进行遗传咨询,根据孕周和临床资料不同采取不同诊断方法.孕妇孕周<23周,有先证者且已明确基因突变类型,抽羊水进行直接基因诊断和间接遗传连锁分析;有先证者但未明确基因突变类型,抽脐血进行间接遗传连锁分析和FⅧ活性检测;孕妇孕周>23周且无先证者,抽脐血做FⅧ活性检测和性别染色体检查,但不能诊断携带者.直接基因诊断采用长距离PCR技术,对F8基因内含子22和内含子1倒位进行检测,找不到倒位者,行核苷酸测序;连锁分析采用F8基因内外的7个位点(DXS1108,F8Civs13,INTRON22,DXS1073,DXS9901,DXS15,DXS8069)以及性别位点(Amelo).产前诊断标本均需做母血污染鉴定.结果 15例产前诊断标本均无母血污染.明确诊断血友病A胎儿5例,其中脐血FⅧ活性<1%的3例,1例伴21三体;F8基因22内含子倒位1例;F8基因23外显子错义突变p.Arg2182Cys 1例.结论对临床不同背景情况下采取不同方案进行HA产前诊断,可提高HA患儿检出率和准确性,最大程度地预防出生缺陷儿的发生.
目的建立臨床不同揹景情況下HA患兒產前診斷方案.方法對前來要求作HA產前診斷的15例孕婦進行遺傳咨詢,根據孕週和臨床資料不同採取不同診斷方法.孕婦孕週<23週,有先證者且已明確基因突變類型,抽羊水進行直接基因診斷和間接遺傳連鎖分析;有先證者但未明確基因突變類型,抽臍血進行間接遺傳連鎖分析和FⅧ活性檢測;孕婦孕週>23週且無先證者,抽臍血做FⅧ活性檢測和性彆染色體檢查,但不能診斷攜帶者.直接基因診斷採用長距離PCR技術,對F8基因內含子22和內含子1倒位進行檢測,找不到倒位者,行覈苷痠測序;連鎖分析採用F8基因內外的7箇位點(DXS1108,F8Civs13,INTRON22,DXS1073,DXS9901,DXS15,DXS8069)以及性彆位點(Amelo).產前診斷標本均需做母血汙染鑒定.結果 15例產前診斷標本均無母血汙染.明確診斷血友病A胎兒5例,其中臍血FⅧ活性<1%的3例,1例伴21三體;F8基因22內含子倒位1例;F8基因23外顯子錯義突變p.Arg2182Cys 1例.結論對臨床不同揹景情況下採取不同方案進行HA產前診斷,可提高HA患兒檢齣率和準確性,最大程度地預防齣生缺陷兒的髮生.
목적건립림상불동배경정황하HA환인산전진단방안.방법대전래요구작HA산전진단적15례잉부진행유전자순,근거잉주화림상자료불동채취불동진단방법.잉부잉주<23주,유선증자차이명학기인돌변류형,추양수진행직접기인진단화간접유전련쇄분석;유선증자단미명학기인돌변류형,추제혈진행간접유전련쇄분석화FⅧ활성검측;잉부잉주>23주차무선증자,추제혈주FⅧ활성검측화성별염색체검사,단불능진단휴대자.직접기인진단채용장거리PCR기술,대F8기인내함자22화내함자1도위진행검측,조불도도위자,행핵감산측서;련쇄분석채용F8기인내외적7개위점(DXS1108,F8Civs13,INTRON22,DXS1073,DXS9901,DXS15,DXS8069)이급성별위점(Amelo).산전진단표본균수주모혈오염감정.결과 15례산전진단표본균무모혈오염.명학진단혈우병A태인5례,기중제혈FⅧ활성<1%적3례,1례반21삼체;F8기인22내함자도위1례;F8기인23외현자착의돌변p.Arg2182Cys 1례.결론대림상불동배경정황하채취불동방안진행HA산전진단,가제고HA환인검출솔화준학성,최대정도지예방출생결함인적발생.
Objective To prenatally diagnose HA fetus with different clinical backgrounds. Methods Genetic tests were performed on 15 gravidas subjected for prenatal diagnosis of HA and different methods were employed for diagnosis according to the gestational weeks and clinical data. Amniotic fluid were taken from pregnant women within 23 gestational weeks for direct genotyping and indirect linkage analysis, since these women had probands with clear-cut mutations. Cordocentesis was performed for linkage analysis in pregnant women over 23 gestational weeks with probands whose types of mutation were unknown, while the FⅧ activity tests were carried out simultaneously. For the pregnant women over 23 gestational weeks without proband, cordocentesis was operated for measurement of FⅧ activity and karyotyping, but carriers of hemophilia A could not be detected in these cases. The introns 22 and 1 inversion of F8 gene were identified by long distance-polymerase chain reaction. Nucleotide sequencing was employed if the gene inversion could not be found and linkage analysis of 7 polymorphic markers, including DXS1108, F8Civs13, INTRON22,DXS1073,DXS9901, DXS15, DXS8069 and sex site (Amelo) were applied eventually. Identification of maternal blood contamination must be done before the tests. Results Fifteen samples were identified without maternal blood contamination. Five fetuses were diagnosed with hemophilia A. Meanwhile there were three pregnant women whose cord blood FⅧ activities were less than 1%. One of them was accompanied by trisomy 21; another had inversion mutation in introns 22 of F8 gene; the remaining one was identified with missense mutation in exon 23 (p. Arg2182Cys) of F8 gene. Conclusions Diverse methods should be applied in prenatal diagnosis of hemophilia A with different clinical backgrounds, for the sake of birth defects prevention.